Psyence Biomedical LTD. valuation and forecast
Explore the models for Psyence Biomedical LTD., adjust their assumptions and compare your own valuation with the platform's.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: share count (1m) is 0.24x the cover-page count (2m).
Price vs value
Under review: share count (1m) is 0.24x the cover-page count (2m). We'll show the comparison once resolved.
Price history
Loading chart…
Third-party market data · may be delayed
PBM valuation questions
- How does Fundamentalytics value Psyence Biomedical LTD.?
- We use the models that fit Psyence Biomedical LTD.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Psyence Biomedical LTD.